×
For best experience we recommend to activate Javascript in your browser.
ZSCAN22 antibody (AA 196-294)
The Mouse Monoclonal anti-ZSCAN22 antibody (Clone 3E9) (ABIN949950) specifically detects ZSCAN22 in WB and ELISA.
The antibody is reactive with Human samples.
Catalog No. ABIN949950
$520.15
Plus shipping costs $50.00
Delivery in 11 to 14 Business Days
Quick Overview for ZSCAN22 antibody (AA 196-294) (ABIN949950)
Target
See all ZSCAN22 Antibodies
ZSCAN22
(Zinc Finger and SCAN Domain Containing 22 (ZSCAN22))
Reactivity
All reactivities for ZSCAN22 antibodies
Human
Host
All hosts for ZSCAN22 antibodies
Mouse
Clonality
All clonalities for ZSCAN22 antibodies
Monoclonal
Conjugate
All conjugates for ZSCAN22 antibodies
This ZSCAN22 antibody is un-conjugated
Application
All applications for ZSCAN22 antibodies
Western Blotting (WB), ELISA
Clone
3E9
Product Details anti-ZSCAN22 Antibody
(hide)
Binding Specificity
All epitopes for ZSCAN22 antibodies
AA 196-294
Purpose
Mouse monoclonal antibody raised against a partial recombinant ZSCAN22.
Sequence
KSVTQQIHFK KTSGPYKDVP TDQRGRESGA SRNSSSAWPN LTSQEKPPSE DKFDLVDAYG TEPPYTYSGK RSSKCRECRK MFQSASALEA HQKTHSRKT
Cross-Reactivity
Human
Characteristics
Antibody Reactive Against Recombinant Protein.
Immunogen
ZSCAN22 (NP_862829.1, 196 a.a. ~ 294 a.a) partial recombinant protein with GST tag. MW of the GST tag alone is 26 KDa.
Isotype
IgG2a
Alternatives
(show)
Application Details
(hide)
Application Notes
Optimal working dilution should be determined by the investigator.
Restrictions
For Research Use only
Handling
(hide)
Buffer
In 1x PBS, pH 7.4
Handling Advice
Aliquot to avoid repeated freezing and thawing.
Storage
-20 °C
Storage Comment
Store at -20°C or lower. Aliquot to avoid repeated freezing and thawing.
Target Details for ZSCAN22
(hide)
Target
ZSCAN22
(Zinc Finger and SCAN Domain Containing 22 (ZSCAN22))
Alternative Name
ZSCAN22
Background
Full Gene Name: zinc finger and SCAN domain containing 22 Synonyms: HKR2,MGC126679,MGC138482,ZNF50
Gene ID
342945
NCBI Accession
NM_181846
Recently viewed
(hide)
Chat with us , powered by LiveChat